- Home
- AMRN vs XBIT Comparison
AMRN vs XBIT Comparison
Compare AMRN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- XBIT
- Stock Information
- Founded
- AMRN 1989
- XBIT 2005
- Country
- AMRN Ireland
- XBIT United States
- Employees
- AMRN N/A
- XBIT 90
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- XBIT Pharmaceuticals and Biotechnology
- Sector
- AMRN Health Care
- XBIT Health Care
- Exchange
- AMRN Nasdaq
- XBIT Nasdaq
- Market Cap
- AMRN 216.0M
- XBIT 93.0M
- IPO Year
- AMRN 1993
- XBIT 2015
- Fundamental
- Price
- AMRN $16.90
- XBIT $2.83
- Analyst Decision
- AMRN Strong Sell
- XBIT
- Analyst Count
- AMRN 1
- XBIT 0
- Target Price
- AMRN $12.00
- XBIT N/A
- AVG Volume (30 Days)
- AMRN 171.7K
- XBIT 184.6K
- Earning Date
- AMRN 07-30-2025
- XBIT 08-11-2025
- Dividend Yield
- AMRN N/A
- XBIT N/A
- EPS Growth
- AMRN N/A
- XBIT N/A
- EPS
- AMRN N/A
- XBIT N/A
- Revenue
- AMRN $214,112,000.00
- XBIT N/A
- Revenue This Year
- AMRN N/A
- XBIT N/A
- Revenue Next Year
- AMRN N/A
- XBIT N/A
- P/E Ratio
- AMRN N/A
- XBIT N/A
- Revenue Growth
- AMRN N/A
- XBIT N/A
- 52 Week Low
- AMRN $7.08
- XBIT $2.50
- 52 Week High
- AMRN $17.49
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- AMRN 71.53
- XBIT 46.44
- Support Level
- AMRN $16.12
- XBIT $2.95
- Resistance Level
- AMRN $17.49
- XBIT $3.32
- Average True Range (ATR)
- AMRN 0.96
- XBIT 0.17
- MACD
- AMRN 0.05
- XBIT 0.01
- Stochastic Oscillator
- AMRN 90.37
- XBIT 40.24
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.